SMAD4 and head and neck cancer: Mutations in the SMAD4 gene have been linked to resistance of platinum-based drugs like carboplatin15,16, and our data suggest that head and neck cancer patients on carboplatin stratified by pre-treatment SMAD4 expression have significantly differential survival between the strata (Fig. 3D).